Ini Lho 'Pangeran Vaksin', Pria India yang Disebut Bisa Akhiri Pandemi COVID-19

ADVERTISEMENT

Ini Lho 'Pangeran Vaksin', Pria India yang Disebut Bisa Akhiri Pandemi COVID-19

AFP - detikHealth
Senin, 08 Nov 2021 14:33 WIB

Jakarta - Pria asal India disebut-sebut punya potensi mengakhiri pandemi COVID-19. Pria ini berniat memproduksi ratusan juta vaksin dan disebarkan ke negara miskin.

Serum Institute of India's Executive Director Adar Poonawalla and his wife Natasha launch the country's first nasal H1N1 vaccine, 'Nasovac', at a news conference in Mumbai on July 14, 2010. India's largest vaccine manufacturer, Serum Institute, announced the launch of its indigenously developed intra-nasal vaccine named Nasovac for preventing H1N1 infections. The single dose vaccine, fitted at the top of a syringe, is just to be sniffed once in each nostril making it a painless procedure. AFP PHOTO/ Punit PARANJPE (Photo by PUNIT PARANJPE / AFP)
Seorang pria India disebut-sebut bisa mengakhiri pandemi COVID-19. Pria itu adalah Adar Poonawalla, CEO Serum Institute of India (SII). (Foto: AFP/PUNIT PARANJPE)
Serum Institute of India's Executive Director Adar Poonawalla and his wife Natasha launch the country's first nasal H1N1 vaccine, 'Nasovac', at a news conference in Mumbai on July 14, 2010. India's largest vaccine manufacturer, Serum Institute, announced the launch of its indigenously developed intra-nasal vaccine named Nasovac for preventing H1N1 infections. The single dose vaccine, fitted at the top of a syringe, is just to be sniffed once in each nostril making it a painless procedure. AFP PHOTO/ Punit PARANJPE (Photo by PUNIT PARANJPE / AFP)
Adar dijuluki 'Pangeran Vaksin dari India', punya kontribusi yang cukup besar dalam pembuatan vaksin COVID-19, salah satu cara mengakhiri pandemi. (Foto: AFP/PUNIT PARANJPE)
Serum Institute of India's Executive Director Adar Poonawalla and his wife Natasha launch the country's first nasal H1N1 vaccine, 'Nasovac', at a news conference in Mumbai on July 14, 2010. India's largest vaccine manufacturer, Serum Institute, announced the launch of its indigenously developed intra-nasal vaccine named Nasovac for preventing H1N1 infections. The single dose vaccine, fitted at the top of a syringe, is just to be sniffed once in each nostril making it a painless procedure. AFP PHOTO/ Punit PARANJPE (Photo by PUNIT PARANJPE / AFP)
Perusahaannya terlibat dalam uji klinis dan produksi vaksin AstraZeneca, salah satu vaksin COVID-19 pertama. (oto: AFP/PUNIT PARANJPE)
Serum Institute of India's Executive Director Adar Poonawalla and his wife Natasha launch the country's first nasal H1N1 vaccine, 'Nasovac', at a news conference in Mumbai on July 14, 2010. India's largest vaccine manufacturer, Serum Institute, announced the launch of its indigenously developed intra-nasal vaccine named Nasovac for preventing H1N1 infections. The single dose vaccine, fitted at the top of a syringe, is just to be sniffed once in each nostril making it a painless procedure. AFP PHOTO/ Punit PARANJPE (Photo by PUNIT PARANJPE / AFP)
Adar dan SII juga berkomitmen untuk memproduksi ratusan juta dosis vaksin dan membagikannya ke negara-negara miskin di dunia. (Foto: AFP/PUNIT PARANJPE)
Ini Lho Pangeran Vaksin, Pria India yang Disebut Bisa Akhiri Pandemi COVID-19
Ini Lho Pangeran Vaksin, Pria India yang Disebut Bisa Akhiri Pandemi COVID-19
Ini Lho Pangeran Vaksin, Pria India yang Disebut Bisa Akhiri Pandemi COVID-19
Ini Lho Pangeran Vaksin, Pria India yang Disebut Bisa Akhiri Pandemi COVID-19

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT